RING CHRISTINE (General Counsel) sold 38.8% of their position (5.79K shares) of NURIX THERAPEUTICS, INC. on the open market
Open‑market sale worth $134.1K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/2/2026ACC: 0001817199-26-000032
Officer· General Counsel
Since Jul 2020
-5.79K
Net shares
Net seller
$134.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5.79K acquired · 11.57K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5.79K
Price / share
$8.72
Trade value
$50.45K
% of position
63.5%
10/2/2026
9.11K→14.90K
Common Stock
Direct
Shares
−5.79K
Price / share
$23.19
Trade value
$134.15K
% of position
38.8%
10/2/2026
14.90K→9.11K
Total
Net shares
+0.00
Net value
-$83.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/2/2026 | M · Option Exercise | +5.79K | $8.72 | $50.45K | 63.5% | 9.11K | 14.90K |
| Common Stock Direct | 10/2/2026 | S · Sale | −5.79K | $23.19 | $134.15K | 38.8% | 14.90K | 9.11K |
| Total | +0.00 | -$83.70K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
5.79K shares
Shares
−5.79K
Strike price
8.72
Held after
111.25K
Exercisable
—
10/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock5.79K shares | 10/2/2026 | M · Option Exercise | −5.79K | 8.72 | — | 111.25K |